⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9301458 | 0.85 | — | — | |
| SCHEMBL9302238 | 0.85 | — | — | |
| SCHEMBL9302276 | 0.82 | — | — | |
| SCHEMBL7902359 | 0.77 | — | — | |
| SCHEMBL9301356 | 0.75 | — | — | |
| SCHEMBL9301559 | 0.75 | — | — | |
| SCHEMBL9302373 | 0.75 | — | — | |
| SCHEMBL18281109 | 0.73 | — | — | |
| SCHEMBL396760 | 0.72 | — | — | |
| SCHEMBL9304198 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11427666-B2 | Silicone-containing acrylic polymers for transdermal drug delivery compositions | NOVEN PHARMACEUTICALS, INC. (US) | 2022-08-30 | — | — | US | disclosed |
| US-20200277424-A1 | SILICONE-CONTAINING ACRYLIC POLYMERS FOR TRANSDERMAL DRUG DELIVERY COMPOSITIONS | NOVEN PHARMACEUTICALS, INC. (US) | 2020-09-03 | — | — | US | disclosed |
| EP-3179989-B1 | SILICONE-CONTAINING ACRYLIC POLYMERS FOR TRANSDERMAL DRUG DELIVERY COMPOSITIONS | NOVEN PHARMA (US) | 2019-06-12 | — | — | EP | disclosed |
| US-20160030362-A1 | SILICONE-CONTAINING ACRYLIC POLYMERS FOR TRANSDERMAL DRUG DELIVERY COMPOSITIONS | NOVEN PHARMACEUTICALS, INC. (US) | 2016-02-04 | — | — | US | disclosed |
| US-5376378-A | Transdermal drug delivery | CIBA-GEIGY CORP. (US) | 1994-12-27 | — | — | US | disclosed |
| US-5288827-A | Drug selivery | CIBA-GEIGY CORPORATION (US) | 1994-02-22 | — | — | US | disclosed |